Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension - sprookjes - yvandenbroek - TriplyDB

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension

http://www.wikidata.org/entity/Q28390972

about

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.Inside epoxyeicosatrienoic acids and cardiovascular disease Cytochrome P450 eicosanoids in hypertension and renal disease Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice Targeting epoxides for organ damage in hypertension Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor Epoxyeicosatrienoic acids, hypertension, and kidney injury Soluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in mice A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation Epoxides and soluble epoxide hydrolase in cardiovascular physiology Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice Elevated urinary urea by high-protein diet could be one of the inducements of bladder disorders Macrophage epoxygenase determines a profibrotic transcriptome signature.Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension.Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury.Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.The effects of hypertension on the cerebral circulation.Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension.Vascular pharmacology of epoxyeicosatrienoic acids Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols.Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency.Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.

P2860

Q24597172-DB402724-A423-4CED-A765-A0DE997F3C0F Q26771815-5BC37FD3-8F75-421C-8739-7279AF4E2D70 Q26849271-7550410B-6421-462B-A2B5-65287F156AE6 Q27334040-29A9647B-38EB-4655-A058-9E2F3CF1A974 Q28252156-407BBB45-85FF-43AD-BC55-57A2FCA589FA Q28252210-035A841C-571A-43FA-BD18-FC332CD64EC2 Q28271874-05486A8C-1B26-4D0D-9382-1BEEF75289F4 Q28281019-3CF2A514-2BE1-4B5A-87F9-4A7E557C03FC Q28304230-044E5651-39EA-4233-B858-066AC4DEAC1D Q28384279-6C8E239A-3E57-46EF-81A8-C0A833EB047E Q28385015-DD98C864-478B-4F8B-B008-F053DA3377A5 Q28385478-B4F2BB1F-E854-4164-AE2D-91FE0DE5833E Q28387558-195E210D-2DC6-467F-B6E2-BA11297CF832 Q28387686-D4EB04D7-636F-4BB6-9D8D-A0C3D3D73FDE Q28387823-700DE951-F0DC-4D42-A9F7-F622EC35A3F1 Q28389024-6C04AC6A-6CFB-496D-B3FE-C0F93E322A74 Q28390006-6D30F459-C2DE-4434-9B9E-7627504DB4D6 Q28393303-12D16819-1427-4310-B912-5E8FB0C39F25 Q28396313-D348B154-0C77-4866-8A64-93F79808AA24 Q28398028-5BEB38BF-7010-4F94-B9A2-501064FE4A8E Q28573682-1C823AD0-9B5F-4AD4-93E8-235730C7F328 Q30273952-E4C1C0CD-0780-4B09-A87C-25C75E9474B5 Q33652488-06514C0D-6801-4050-8793-C9B15F77EB24 Q33731887-9A2FDCE0-1DE4-440E-9338-678D14830CF3 Q33882374-A6BB4F3C-EC48-4E85-A459-29A3AC61BC29 Q34205948-54BCE34B-F573-4FC5-B465-438A1BA3B535 Q34229608-4F745C47-4529-4943-A13E-CAC8741503A0 Q34355908-330E1DED-8E73-424B-A736-D4EF1BF6F856 Q34378817-A63D7804-BCD4-4A2B-A614-2CC9633294E5 Q34790113-BE5F6CD7-33CB-49F8-8E88-761AB2589940 Q35056911-2B307648-3143-4C06-80EF-B7B8DA51D42E Q35115765-98738E31-17FC-4A7A-8542-398D7AF6F325 Q35543421-C5B77C0F-F208-42E2-9DE5-CB267918EBE0 Q35608633-7FF7C544-64A5-46EA-B2CC-DBD5BC61CBF1 Q36027183-279F9D28-3DD2-4DA1-BDAE-C9DA674B14DC Q36056415-E16C2597-4717-494B-9E90-2EFD600567D6 Q36074329-F63BE674-2022-4578-892B-9EF4594AFF21 Q36124088-50FA4A1A-EEFA-4C2E-B08F-81FF05889C32 Q36527885-90412528-DB18-4184-BED3-AF5D1D9D9B6F Q36546979-B66D8A64-8D81-42E1-9E7B-06BEAF3E7C91

P2860

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension

http://www.wikidata.org/entity/Q28390972

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@ast

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@en

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@nl

type

label

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@ast

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@en

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@nl

prefLabel

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@ast

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@en

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@nl

P1433

Q28390972-F55A25B5-2A13-4D7E-BC2A-D9C45FB6722E

P1476

Q28390972-D1B11939-7FF8-4CA3-889A-9D6CA8D136BD

P2093

Q28390972-0CB4821C-2E76-4CB9-9F62-1F1253368517

Q28390972-18456188-4FDD-4F10-84E4-3DD6462F1DD9

Q28390972-52626A51-1C5B-479C-8C6E-C3A9A4F1B619

Q28390972-6C7B8B6E-85EE-4EAD-8487-21D5C4363094

Q28390972-99865ECF-5DC6-476C-A7AC-9382B78243E3

Q28390972-BD993B9D-D7D7-4643-B71C-5969BC6E06EB

Q28390972-F8EBF488-5333-4F86-8F68-BFF637461654

P2860

Q28390972-09372297-02AD-4EED-BDA9-A2347E24BAA4

Q28390972-107B4E64-C159-474C-9146-B4A2100F3962

Q28390972-12FFE345-438C-49B7-8B9D-3F68047DE0FD

Q28390972-28A95BAD-CE63-4614-9AC9-43C53118FFBE

Q28390972-35A12061-A6CC-476F-8450-81B041B746A4

Q28390972-37D053E3-3F63-43FB-8AD0-161592AB2A3D

Q28390972-39783DC7-2055-485F-A865-898DF233F695

Q28390972-401EDFE3-6BEF-4FE1-A150-4F6D89C89DE8

Q28390972-40703276-A2C3-4EA3-BE09-ED92C75843CD

Q28390972-43117D9F-89F9-49BC-AD6F-1A41C4391138

P304

Q28390972-93BDB67E-2EBB-4CDF-B0BF-EA8C87F8CCFD

P31

Q28390972-C7AF6130-4656-4AA8-BB03-0CB2B5CA9F19

P356

Q28390972-AA20D376-59DA-4B8B-85F2-726965948D5C

P407

Q28390972-80BC6FD6-7348-4E95-A186-56870AF99041

P433

Q28390972-B76045ED-4961-4619-905C-CD3389070CC0

P478

Q28390972-70036BC9-4F78-469E-84F2-ECDA251FA5A0

P50

Q28390972-2A2BBB6B-C873-4E14-9EB2-8E863FC382EC

P577

Q28390972-691CE16E-D026-4289-A9FA-BA0E212E5434

P698

Q28390972-9100FCEF-5581-4DCA-ACD7-94A72CDBCFA9

P921

Q28390972-AB81B714-744C-47DF-9194-EEDBE879BEE5

Q28390972-CD48AD9A-F97A-4465-B2BF-B2025AABE5F3

P932

Q28390972-09A73365-E8C6-4344-A461-544077C3CAB3

P356

AJPRENAL.00098.2009

P1433

American Journal of Physiology - Renal Physiology

P1476

Soluble epoxide hydrolase gene ...... on with DOCA-salt hypertension

@en

P2093

Jeffrey E Quigley

http://www.w3.org/2001/XMLSchema#string

John D Imig

http://www.w3.org/2001/XMLSchema#string

Marlina Manhiani

http://www.w3.org/2001/XMLSchema#string

Michael W Brands

http://www.w3.org/2001/XMLSchema#string

Sarah F Knight

http://www.w3.org/2001/XMLSchema#string

Shiva Tasoobshirazi

http://www.w3.org/2001/XMLSchema#string

TarRhonda Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Cytochrome P450 2C is an EDHF synthase in coronary arteries

New role for epoxyeicosatrienoic acids as anti-inflammatory mediators

Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia

Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function

P304

F740-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00098.2009

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P50

Bruce D. Hammock

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19553349

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2739707

http://www.w3.org/2001/XMLSchema#string